Study: Nuplazid Demonstrates its Impact in Parkinson’s Disease Patients
source: pixabay.com

Study: Nuplazid Demonstrates its Impact in Parkinson’s Disease Patients

  According to a recent article in Parkinson’s News Today, results of an extension study confirm that FDA approved Nuplazid (pimavanserin) reduces the severity of delusions and hallucinations in Parkinson’s disease…

Continue Reading Study: Nuplazid Demonstrates its Impact in Parkinson’s Disease Patients

A Study Confirms Significant Benefits from Deep Brain Stimulation for Late-stage Parkinson’s Patients

Parkinson's News Today recently published an article featuring a study in Italy showing the benefits of deep brain stimulation in patients with late-stage Parkinson’s disease. The history of the subthalamic…

Continue Reading A Study Confirms Significant Benefits from Deep Brain Stimulation for Late-stage Parkinson’s Patients
$950,000 Raised to Fund NeuroMotor Pen, A Diagnostic Tool for Neurological Disorders
QuinceMedia / Pixabay

$950,000 Raised to Fund NeuroMotor Pen, A Diagnostic Tool for Neurological Disorders

Every day, the world becomes increasingly technological. With this comes advances in many realms, from healthcare to education. Recently, says Parkinson's News, medical technology company Manus Neurodynamica received £750,000 (approx. $950,000)…

Continue Reading $950,000 Raised to Fund NeuroMotor Pen, A Diagnostic Tool for Neurological Disorders
High Uric Acid in Men with Parkinson’s Increases Risk for Levodopa-Induced Dyskinesia
source: pixabay.com

High Uric Acid in Men with Parkinson’s Increases Risk for Levodopa-Induced Dyskinesia

As reported in Parkinson’s News Today, a new study has found that high blood levels of the antioxidant uric acid is correlated with heightened risk of developing levodopa-induced dyskinesia (LID)…

Continue Reading High Uric Acid in Men with Parkinson’s Increases Risk for Levodopa-Induced Dyskinesia
Study: Nuplazid as a Treatment for Psychosis in Parkinson’s Disease Patients
source: pixabay.com

Study: Nuplazid as a Treatment for Psychosis in Parkinson’s Disease Patients

Acadia Pharmaceuticals recently released the results of their Phase 3 trial of Nuplazid, a treatment for the psychosis that Parkinson's disease patients experience. This medication has been approved since 2016,…

Continue Reading Study: Nuplazid as a Treatment for Psychosis in Parkinson’s Disease Patients
Parkinson’s Disease: Vercise Deep Brain Stimulation Demonstrates Efficacy for Over a Year
source: pixabay.com

Parkinson’s Disease: Vercise Deep Brain Stimulation Demonstrates Efficacy for Over a Year

According to a story from Parkinson's News Today, the Vercise system, developed by Boston Scientific as a method of deep brain stimulation, was able to provide benefit to Parkinson's disease…

Continue Reading Parkinson’s Disease: Vercise Deep Brain Stimulation Demonstrates Efficacy for Over a Year
This Skin Patch was Able to Improve Motor Function in Advanced Parkinson’s Disease
source: pixabay.com

This Skin Patch was Able to Improve Motor Function in Advanced Parkinson’s Disease

According to a story from Parkinson's News Today, ropinirole (marketed as Requip) skin patches proved capable of improving motor function in patients with advanced Parkinson's disease when compared to placebo.…

Continue Reading This Skin Patch was Able to Improve Motor Function in Advanced Parkinson’s Disease